OBJECTIVE: We aimed to assess the health impact of a national control programme targeting schistosomiasis and intestinal nematodes in Uganda, which has provided population-based anthelmintic chemotherapy since 2003. METHODS: We conducted longitudinal surveys on infection status, haemoglobin concentration and clinical morbidity in 1871 randomly selected schoolchildren from 37 schools in eight districts across Uganda at three time points - before chemotherapy and after one year and two years of annual mass chemotherapy. FINDINGS: Mass treatment with praziquantel and albendazole led to a significant decrease in the intensity of Schistosoma mansoni - 70% (95% confidence interval (CI): 66-73%) after one year and 82% (95% CI: 80-85%) after two years of treatment. Intensity of hookworm infection also decreased (75% and 93%; unadjusted). There was a significant increase in haemoglobin concentration after one (0.135 g/dL (95% CI: 0.126-0.144)) and two years (0.303 g/dL (95% CI: 0.293-0.312)) of treatment, and a significant decrease in signs of early clinical morbidity. The impact of intervention on S. mansoni prevalence and intensity was similar to that predicted by mathematical models of the impact of chemotherapy on human schistosomiasis. Improvements in haemoglobin concentration were greatest among children who were anaemic or harbouring heavy S. mansoni infection at baseline. CONCLUSION: Anthelmintic treatment delivered as part of a national helminth control programme can decrease infection and morbidity among schoolchildren and improve haemoglobin concentration.
OBJECTIVE: We aimed to assess the health impact of a national control programme targeting schistosomiasis and intestinal nematodes in Uganda, which has provided population-based anthelmintic chemotherapy since 2003. METHODS: We conducted longitudinal surveys on infection status, haemoglobin concentration and clinical morbidity in 1871 randomly selected schoolchildren from 37 schools in eight districts across Uganda at three time points - before chemotherapy and after one year and two years of annual mass chemotherapy. FINDINGS: Mass treatment with praziquantel and albendazole led to a significant decrease in the intensity of Schistosoma mansoni - 70% (95% confidence interval (CI): 66-73%) after one year and 82% (95% CI: 80-85%) after two years of treatment. Intensity of hookworm infection also decreased (75% and 93%; unadjusted). There was a significant increase in haemoglobin concentration after one (0.135 g/dL (95% CI: 0.126-0.144)) and two years (0.303 g/dL (95% CI: 0.293-0.312)) of treatment, and a significant decrease in signs of early clinical morbidity. The impact of intervention on S. mansoni prevalence and intensity was similar to that predicted by mathematical models of the impact of chemotherapy on humanschistosomiasis. Improvements in haemoglobin concentration were greatest among children who were anaemic or harbouring heavy S. mansoniinfection at baseline. CONCLUSION: Anthelmintic treatment delivered as part of a national helminth control programme can decrease infection and morbidity among schoolchildren and improve haemoglobin concentration.
Authors: S Brooker; H Marriot; A Hall; S Adjei; E Allan; C Maier; D A Bundy; L J Drake; M D Coombes; G Azene; R G Lansdown; S T Wen; M Dzodozmenyo; J Cobbinah; N Obro; C M Kihamia; W Issae; L Mwanri; M R Mweta; A Mwaikemwa; M Salimu; P Ntimbwa; V M Kiwelu; A Turuka; D R Nkungu; J Magingo Journal: Trop Med Int Health Date: 2001-12 Impact factor: 2.622
Authors: J A Kurtzhals; M M Addae; B D Akanmori; S Dunyo; K A Koram; M A Appawu; F K Nkrumah; L Hviid Journal: Trans R Soc Trop Med Hyg Date: 1999 Nov-Dec Impact factor: 2.184
Authors: P Magnussen; B Ndawi; A K Sheshe; J Byskov; K Mbwana; N O Christensen Journal: Trans R Soc Trop Med Hyg Date: 2001 Jan-Feb Impact factor: 2.184
Authors: Giovanna Raso; Eliézer K N'Goran; Abale Toty; Anne Luginbühl; Cynthia A Adjoua; Norbert T Tian-Bi; Isaac I Bogoch; Penelope Vounatsou; Marcel Tanner; Jürg Utzinger Journal: Trans R Soc Trop Med Hyg Date: 2004-01 Impact factor: 2.184
Authors: Lorenzo Savioli; Sally Stansfield; Donald A P Bundy; Arlene Mitchell; Rita Bhatia; Dirk Engels; Antonio Montresor; Maria Neira; Ali Mohammed Shein Journal: Trans R Soc Trop Med Hyg Date: 2002 Nov-Dec Impact factor: 2.184
Authors: M Booth; B J Vennervald; N B Kabatereine; F Kazibwe; J H Ouma; C H Kariuki; E Muchiri; H Kadzo; E Ireri; G Kimani; J K Mwatha; D W Dunne Journal: Trans R Soc Trop Med Hyg Date: 2004-02 Impact factor: 2.184
Authors: C Simoonga; J Utzinger; S Brooker; P Vounatsou; C C Appleton; A S Stensgaard; A Olsen; T K Kristensen Journal: Parasitology Date: 2009-07-23 Impact factor: 3.234
Authors: Martin Omedo; Michael Ogutu; Alphonce Awiti; Rosemary Musuva; Geoffrey Muchiri; Susan P Montgomery; W Evan Secor; Pauline Mwinzi Journal: Am J Trop Med Hyg Date: 2014-09-22 Impact factor: 2.345
Authors: Poppy H L Lamberton; Sarah C Hogan; Narcis B Kabatereine; Alan Fenwick; Joanne P Webster Journal: Am J Trop Med Hyg Date: 2010-12 Impact factor: 2.345
Authors: Angela Pinot de Moira; Frances M Jones; Shona Wilson; Edridah Tukahebwa; Colin M Fitzsimmons; Joseph K Mwatha; Jeffrey M Bethony; Narcis B Kabatereine; David W Dunne Journal: Infect Immun Date: 2012-10-15 Impact factor: 3.441
Authors: Simon Brooker; Narcis B Kabatereine; Jennifer L Smith; Denise Mupfasoni; Mariam T Mwanje; Onésime Ndayishimiye; Nicholas Js Lwambo; Deborah Mbotha; Peris Karanja; Charles Mwandawiro; Eric Muchiri; Archie Ca Clements; Donald Ap Bundy; Robert W Snow Journal: Int J Health Geogr Date: 2009-07-09 Impact factor: 3.918